BACKGROUND/OBJECTIVE: Impairments in metabolic flexibility (MF) and substrate handling are associated with metabolic syndrome. However, it is unknown whether metabolic inflexibility causes insulin resistance. We therefore measured MF and substrate handling before and after 8 weeks of overfeeding in initially healthy adults as a model of the early stages of insulin resistance. SUBJECTS/METHODS: Twenty-nine healthy men (27 ± 5 years old; body mass index 25.5 ± 2.3 kg m − 2 ) were overfed by 40% above baseline energy requirements for 8 weeks and gained 7.6 ± 2.1 kg of weight. Before and after overfeeding, energy expenditure, substrate oxidation and MF were measured in two ways: (a) during 1 day of eucaloric feeding in a whole-room indirect calorimeter and (b) during a two-step hyperinsulinemic-euglycemic clamp. RESULTS: Eight weeks of overfeeding decreased insulin sensitivity at low and high doses of insulin (P = 0.001 and P = 0.06, respectively). This was accompanied by decreases in the respiratory quotient (RQ) while sleeping (from 0.877 ± 0.020 to 0.864 ± 0.026; P = 0.05) and at low insulin levels during the clamp (from 0.927 ± 0.047 to 0.907 ± 0.032; P = 0.01). Overfeeding did not affect MF as measured during a clamp (P ⩾ 0.17), but it tended to increase 24-h MF (awake RQ − sleep RQ) as measured by chamber by 0.010 ± 0.028 (P = 0.08). In terms of substrate oxidation, overfeeding increased protein oxidation by 13 ± 23 g day − 1 (P = 0.003) and tended to increase fat oxidation by 6 ± 16 g day − 1 (P = 0.07) but did not affect carbohydrate oxidation (P = 0.64). Individuals with greater metabolic adaptation to overfeeding had higher carbohydrate oxidation rates (r = 0.66, P = 8 × 10 − 5 ) but not fat oxidation rates (P = 0.09). CONCLUSIONS: The early stages of insulin resistance are accompanied by modest declines in the RQs during sleep and during a clamp, with no changes in fasting RQ or signs of metabolic inflexibility. Our data therefore suggest that metabolic inflexibility does not cause insulin resistance.
INTRODUCTION
Metabolic flexibility (MF) is the capacity to adjust substrate oxidation rates in response to changes in fuel availability. 1 It represents the plasticity in switching between oxidizing fatty acids and carbohydrates. In vivo, MF is operationally defined as the increase in respiratory quotient (RQ) between fasting and postprandial states, as measured either in response to a mixed meal or during a hyperinsulinemic-euglycemic clamp. 1 Impairments in MF have been reported to occur in obesity, 2,3 insulin resistance and prediabetes 4, 5 and diabetes. [6] [7] [8] This 'metabolic inflexibility' typically manifests itself as both lower fat oxidation in the fasting state (higher fasting RQ) and impaired stimulation of carbohydrate oxidation during feeding (lower postprandial RQ), resulting in a smaller difference in RQ between fasting and feeding. 1, 3, 4, [6] [7] [8] [9] [10] However, some studies have reported normal RQs during fasting in individuals with obesity or diabetes, with the implication that mostly postprandial substrate oxidation is altered. 3, 9, 11 A related oxidative factor that has been invoked to explain the development of metabolic syndrome is a lower capacity to upregulate fat oxidation in response to fat overload. Such impaired fat oxidation promotes the accumulation of acyl-CoA and its derivatives, leading to lipotoxicity, ectopic fat deposition and insulin resistance. 1, 2, [12] [13] [14] For instance, women with obesity who were placed on a high-fat diet were unable to increase fat oxidation and therefore stored more of the excess lipid, relative to lean controls. 14 This is supported by other studies reporting impaired fatty acid oxidation in individuals with obesity. 3, 15, 16 Moreover, long-term longitudinal studies find that individuals with higher 24-h RQs (indicative of lower fat oxidation) gain more weight over time, even after controlling for acute energy balance or energy expenditure (EE). 17, 18 Thus, the ability to maintain high rates of fat oxidation in the face of positive energy balance (or a high-fat diet) may enable greater metabolic adaptation and help resist body weight gain.
The physiological mechanisms responsible for these impairments in substrate oxidation have been linked to defects in glucose transport, 8, 9, 19, 20 failure of insulin to suppress fatty acid release from adipose tissue, 12, 19, 21, 22 lower glucose oxidation rates within skeletal muscle, 21 failure to suppress hepatic glucose production 19, 21 and mitochondrial dysfunction. 23, 24 However, whether metabolic inflexibility merely reflects the net effect of physiological changes on fuel availability-or whether it reflects an intrinsic oxidative defect-is unknown. Some studies have shown that adjusting MF for the glucose disposal rate (GDR) 9, 11, 25 or measuring MF at matched GDR 8 causes the differences to vanish between lean individuals and individuals with obesity or diabetes, which suggests that metabolic inflexibility stems mostly 1 from lower rates of glucose transport. Conversely, Faerch and Vaag 5 found that MF is still lower in individuals with prediabetes, even after adjusting for both insulin sensitivity and body mass index, suggesting instead that metabolic inflexibility may precede the onset of insulin resistance. In addition, Thorburn et al. 26 reported that individuals with diabetes still have lower glucose oxidation rates and consequently higher nonoxidative GDRs even at matched GDR. Because fat oxidation rates were identical at matched GDR in this study, this suggests that at least part of metabolic inflexibility is driven by impairments in carbohydrate partitioning.
Taken together, it is thus unclear when and how impairments in MF arise and the degree to which they are intrinsic defects vs reflections of fuel availability. We therefore investigated MF and substrate oxidation in healthy men who were overfed by 40% for 8 weeks as a model of the early stages of insulin resistance. We hypothesized that, after overfeeding, MF and substrate oxidation would be impaired to a larger extent than insulin sensitivity, suggesting that metabolic inflexibility develops prior to the onset of insulin resistance.
SUBJECTS AND METHODS

Participants and dietary intervention
This study was approved by Pennington Biomedical Research Center (PBRC)'s institutional review board, registered on clinicaltrials.gov (NCT01672632) and conducted in accord with the Helsinki Declaration of 1975. All participants provided written informed consent prior to enrolling in the study. Primary outcome results have been previously described in detail. 27 Briefly, males and females aged 20-40 years with a body mass index between 22.5 and 32.5 kg m − 2 were eligible to participate. Exclusion criteria included significant medical problems, evidence of chronic disease and use of certain medications or substances, as previously described. 27 Only males (N = 29 out of the 35 completers) are included in this analysis. Participants were overfed by 40% for 8 weeks (56 days), with metabolic testing performed for 3 days before and after the overfeeding intervention under eucaloric conditions. Prior to baseline testing, participants' EE values were measured over a 2-week period using doubly labeled water. 28 During the second week, they were fed a eucaloric diet to establish their weight maintenance energy intake. 29 The average of the weight maintenance energy intake during the second week and EE over 2 weeks was multiplied by 1.4 to account for physical activity and then rounded to the closest 419 kJ day − 1 (100 kcal day − 1 ) to determine each individual's overfeeding prescription. Meals were prepared by the PBRC metabolic kitchen and were composed of 41% carbohydrate, 15% protein and 44% fat (40% saturated, 37% monounsaturated and 23% polyunsaturated fatty acids), yielding a food quotient (RQ of the diet) of 0.832. Participants ate all meals (3 per day, 7 days a week) at PBRC under supervision and were not allowed to consume any other food but were otherwise free living. During the 3 days of postintervention testing, participants were fed a new eucaloric diet according to their new body weight, using the EE equation derived in Heilbronn et al. 29 Body composition was measured by dual-energy X-ray absorptiometry (QDR 4500A; Hologics, Bedford, MA, USA).
Respiratory chamber
Before and after overfeeding, 24-h EE and substrate oxidation were measured at thermoneutrality in a whole-room indirect calorimeter. 30 Participants entered the chamber at 0800 hours, were fed three meals and one snack and were not allowed to exercise. Sleep EE (SEE) and sleep RQ were assessed between 0200 and 0500 hours and included all minutes during which activity as measured by radar was o 1%. Oxygen and carbon dioxide production and 24-h urinary nitrogen excretion were used to calculate EE, as well as oxidation of carbohydrates, fat and protein. 31 Because RQ is influenced by energy balance, RQ values were adjusted for energy balance by regressing RQs (24-h, awake or sleep) vs energy balance (24-h energy intake minus EE). Chamber MF was defined as the difference between the awake RQ and sleep RQ. The thermic effect of food was determined by subtracting SEE from the y intercept of the regression of EE vs percentage of activity, using the data averaged in 15-min intervals, and was expressed as a percentage of energy intake. 32 Hyperinsulinemic-euglycemic clamp Insulin sensitivity was measured using a two-step hyperinsulinemiceuglycemic clamp. Insulin was infused for 180 min at 10 mIU min − 1 m − 2 (low-dose insulin), followed by 150 min at 50 mIU min − 1 m − 2 (high-dose insulin). Infusion of a 20% glucose solution was adjusted to maintain plasma glucose at 90 mg dl − 1 . Insulin sensitivity was assessed as the glucose infusion rate (GIR) during the final 30 min of each step of the clamp (steady state) 33 and was expressed per kg of estimated metabolic weight (fat-free mass + 17.7 kg). 34 Resting metabolic rate and RQ were measured using a DeltaTrac hood indirect calorimeter (Sensor Medics, Yorba, CA, USA) for 30 min fasting and for 30 min during each steady-state period of the clamp. The oxidative component of the glucose infusion rate was calculated as described by Jequier et al., 31 while the nonoxidative component was calculated as the difference between the total glucose infusion rate and its oxidative component. Clamp whole-body MF was defined as the difference between the high-dose or low-dose steady-state RQ and the fasting RQ.
Statistical analyses
Statistical analyses were performed using SAS 9.1.3 (SAS Institute, Cary, NC, USA), Excel (Microsoft Corporation, Redmond, WA, USA) and Mathematica 10.0 (Wolfram Research, Champaign, IL, USA). All data are presented as mean ± s.d. Changes between baseline and post-overfeeding values were analyzed by paired, two-tailed t-tests or Wilcoxon signed rank tests, depending on the normality of the data as determined using the Shapiro-Wilk test. Associations between RQs or MFs and other metabolic parameters were analyzed using linear regression. For all statistical tests, the false positive rate was set at α = 0.05. Finally, correlation analyses were performed among multiple variables using the Bonferroni correction applied to 63 exploratory variables; all other data are non-exploratory and were analyzed for significance without the Bonferroni correction. All P-values in this manuscript are reported as raw (unadjusted) values.
RESULTS
Participant characteristics
Twenty-nine men aged 27 ± 5 years with a mean body mass index of 25.5 ± 2.3 kg m − 2 completed the 8-week overfeeding protocol, as reported in Johannsen et al. 27 During the overfeeding phase, participants consumed an average of 17.73 ± 1.97 MJ day − 1 (4235 ± 470 kcal day − 1 ) vs 12.78 ± 1.66 MJ day − 1 (3054 ± 396 kcal day − 1 ) at baseline. As shown in Table 1 , the mean weight gain was 7.6 ± 2.1 kg, of which about 55% was fat mass (4.2 ± 1.4 kg; P = 1 × 10 − 15 ) and the remaining was fat-free mass (3.4 ± 1.5 kg; P = 2 × 10 − 12 ). These changes were accompanied by increases in visceral adipose tissue (P = 9 × 10 − 10 ) and total cholesterol (P = 4 × 10 − 7 ), whereas the increase in intrahepatic lipid was not significant (P = 0.20). As previously reported, 27 insulin sensitivity at low-dose insulin decreased by 18% (2.87 ± 0.94 vs 2.35 ± 0.07 mg min − 1 kg − 1 ; Δ = − 0.42 ± 0.65 mg min − 1 kg − 1 ; P = 0.001), whereas insulin sensitivity at high-dose insulin only trended toward a decrease after 8 weeks of overfeeding (11.51 ± 2.54 vs 10.91 ± 2.46 mg min − 1 kg − 1 ; Δ = − 0.60 ± 1.56 mg min − 1 kg − 1 ; P = 0.06).
RQs and MF RQs were measured both through a 1-day stay in a respiratory chamber (chamber RQs; Figure 1a ) and using an indirect hood calorimeter before and during a 2-step hyperinsulinemiceuglycemic clamp (clamp RQs; Figure 1b ). As shown in Figure 1a , sleep RQ decreased from 0.877 ± 0.020 at baseline to 0.864 ± 0.026 after 8 weeks of overfeeding (ΔRQ = − 0.013 ± 0.034; P = 0.05). By contrast, there were no statistically significant changes in the 24-h RQ (0.896 ± 0.019 vs 0.891 ± 0.025; ΔRQ = − 0.005 ± 0.025; P = 0.29) or the awake RQ (0.900 ± 0.022 vs 0.896 ± 0.027; ΔRQ = − 0.004 ± 0.025; P = 0.39) in response to overfeeding. Figure 1b shows the fasting RQ and the RQs measured during low-dose insulin (low ins) and high-dose insulin (high ins)
infusions during a 2-step clamp. The fasting RQ was unchanged in response to overfeeding (0.874 ± 0.044 vs 0.866 ± 0.032; ΔRQ = − 0.008 ± 0.044; P = 0.34). During insulin and glucose infusion, the RQ during low-dose insulin infusion was lower by − 0.020 ± 0.039 in response to overfeeding (0.927 ± 0.047 vs 0.907 ± 0.032; P = 0.01). Similarly, the RQ during high-dose insulin infusion tended to be lower by − 0.017 ± 0.043 after 8 weeks of overfeeding (0.973 ± 0.046 vs 0.957 ± 0.039; P = 0.08). Notably, this trend in the high-dose insulin RQ data becomes significant if a single outlier (RQ = 0.838; 43 s.d. from the mean) is excluded (0.979 ± 0.038 to 0.957 ± 0.037; ΔRQ = − 0.022 ± 0.036; P = 0.01).
As shown in Figure 1c , overfeeding tended to increase the 24-h MF (awake RQ − sleep RQ) as measured by respiratory chamber from 0.023 ± 0.022 to 0.033 ± 0.025 (ΔMF = 0.010 ± 0.028; P = 0.08). As shown in Figure 1a , the increase in 24-h MF was driven more by decreases in the sleep RQ than by changes in the awake RQ. However, overfeeding did not impact MF as measured by the clamp method ( Figure 1d) ; MF values were unchanged at low insulin (0.054 ± 0.036 vs 0.040 ± 0.041; ΔMF = − 0.014 ± 0.045; P = 0.17) and high insulin (0.098 ± 0.040 vs 0.089 ± 0.048; ΔMF = − 0.009 ± 0.045; P = 0.41) levels. Figure 2 shows that overfeeding enhanced 24-h protein oxidation from 94 ± 18 g day − 1 at baseline to 108 ± 20 g day − 1 postoverfeeding (Δ = 13 ± 23 g day − 1 ; P = 0.003); this increase was still significant after adjusting for increased energy intake based on weight gain (P = 0.05). Fat oxidation also tended to increase, raising from 45 ± 18 g day − 1 at baseline to 51 ± 19 g day − 1 following overfeeding (Δ = 6 ± 16 g day − 1 ; P = 0.07), in line with the changes in body weight. However, 24-h carbohydrate oxidation remained unchanged (329 ± 46 vs 335 ± 53 g day − 1 ; Δ = 6 ± 52 g day − 1 ; P = 0.64) in response to overfeeding. Oxidative and nonoxidative glucose disposal Previously, we reported that 8 weeks of overfeeding decreased insulin sensitivity at low levels of insulin by 18% (P = 0.001) and by a marginal 5% (P = 0.06) at high levels of insulin. 27 Here we investigated the differences between oxidative and nonoxidative components of glucose disposal to probe carbohydrate partitioning. As depicted in Figure 3a , the oxidative disposal rate at low-dose insulin declined slightly by − 0.16 ± 0.69 mg min − 1 kg − 1 (from 2.30 ± 0.56 to 2.14 ± 0.47 mg min − 1 kg − 1 ; P = 0.03), whereas the nonoxidative disposal rate decreased more substantially by − 0.48 ± 0.69 mg min − 1 kg − 1 (from 1.24 ± 0.74 to 0.76 ± 0.66 mg min − 1 kg − 1 ; P = 0.01). However, both the oxidative component (3.18 ± 0.75 vs 3.05 ± 0.74 mg min − 1 kg − 1 ; Δ = − 0.13 ± 0.72 mg min − 1 kg − 1 ; P = 0.20) and nonoxidative component (8.97 ± 1.92 vs 8.87 ± 1.77 mg min − 1 kg − 1 ; Δ = − 0.10 ± 1.22 mg min − 1 kg − 1 ; P = 0.69) of glucose disposal under high-dose insulin concentrations were unchanged (Figure 3b ).
24-h substrate oxidation
Thermic effect of food and thermic effect of glucose We also investigated postprandial thermic responses-namely, the thermic effects of a mixed meal and of glucose. As shown in Figure 4a , the thermic effect of 1 day of feeding (mixed meals) as measured by respiratory chamber method was unaffected by long-term overfeeding (from 8.1 ± 4.3% to 9.4 ± 5.3%; Δ% = 1.3 ± 5.6%; P = 0.27). Similarly, the thermic effect of glucose as measured during the high-dose insulin stage of the clamp did not change at the end of the 8-week intervention (3.1 ± 2.1% vs 2.6 ± 3.2%; Δ% = − 0.4 ± 3.2%; P = 0.49; Figure 4b ).
Relationship to metabolic adaptation Finally, we tested whether alterations in substrate oxidation may be linked to metabolic adaptation, defined here as the increase in SEE beyond that which can be explained by weight gain (percent change in SEE measured − SEE predicted ). 35 Metabolic adaptation correlated most strongly with the change in sleep RQ in response to overfeeding (r = 0.66, 95% CI: 0.38-0.83; P = 8 × 10 − 5 ). Namely, participants whose sleep RQs remained higher after overfeeding had higher levels of metabolic adaptation. This translated into clear differences in substrate oxidation. Metabolic adaptation correlated with increases in carbohydrate oxidation rates (r = 0.64, 95% CI: 0.35-0.82; P = 0.0001; Figure 5a ) but not with changes in Figure 2 . Long-term overfeeding increased 24-h protein oxidation (P = 0.003) and similarly tended to increase fat oxidation (P = 0.07) in response to 1 day of eucaloric feeding, while carbohydrate oxidation was unaltered (P = 0.64). *P ⩽ 0.05, y Pp0.10. fat oxidation rates after Bonferroni correction (P = 0.09; Figure 5b ). However, there was no correlation between the percentage of body weight gained during overfeeding and either baseline MF as measured by the chamber (P = 0.95) or the change in MF (P = 0.16).
DISCUSSION
Mounting evidence links impairments in MF-the ability to switch between oxidizing lipid and carbohydrate-to obesity, insulin resistance and diabetes. Moreover, nondiabetic adults with higher 24-h RQs gain more weight than those with lower RQs, even after adjusting for energy balance or EE. 17, 18 Together, this suggests that alterations in substrate handling may drive weight gain and the development of metabolic syndrome. However, it is unclear whether metabolic inflexibility is a cause or consequence of insulin resistance. We therefore investigated the impact of 8 weeks of 40% overfeeding on insulin sensitivity, MF and substrate oxidation in 29 healthy men. Eight weeks of overfeeding with significant weight gain decreased insulin sensitivity and lowered or tended to lower the RQs during a two-stage clamp but did not change the fasting RQ. The decline in RQ with glucose infusion but not in the fasting state suggests some impairments in postprandial carbohydrate handling. However, the changes in MF as measured by the clamp method did not reach significance, suggesting that insulin resistance takes root before MF starts to decline. This conflicts with the limited data available from other studies. One study reported a decline in MF in adults aged 35-65 after 4 weeks of high-fat overfeeding, 36 while a 3-week study in middle-age overweight and obese individuals reported a decrease in MF on a eucaloric high-fat diet but no changes in insulin sensitivity. 37 One reason for the discrepancy may be that we investigated the change in MF in significantly younger, initially non-insulinresistant individuals, rather than in older and/or more overweight individuals. The compensatory metabolic responses may therefore differ by age and/or health status. A second reason may be that we measured MF under eucaloric conditions, rather than in response to a high-calorie or high-fat challenge.
It is important to realize that measuring MF via the clamp method induces a non-physiological, steady-state condition wherein plasma glucose is normal but insulin levels are held at high constant levels, thus suppressing circulating free fatty acids. It is worth considering whether MF should be measured instead under daily physiological conditions-that is, measured by respiratory chamber over the course of a normal day and including all feeding episodes. Such conditions avoid the confounding factor of different GDRs during a clamp and avoid non-physiologically high levels of insulin. Moreover, the clamp method of measuring MF misses out on the dynamic 'real-world' nature of substrate oxidation, including non-steady-state conditions and night-day differences in substrate oxidation, which may be affected by sleep-wake cycles and/or the circadian clock. For example, we should not assume that substrate oxidation at night while subjects are asleep is the same as when they are awake and fasting during the daytime. Indeed, in our study, whole-body MF measured by the chamber method tended to improve, rather than to decrease, with overfeeding. The increase in 24-h MF was driven by a decrease in the sleep RQ, implying increased fat oxidation and/or decreased carbohydrate oxidation at night. Interestingly, we found that overfeeding affected only the sleep RQ but not the awake RQ. Individuals with a family history of diabetes are known to have a lower sleep RQ but not awake RQ than GDR-matched control subjects, 23 so a change in substrate oxidation during sleep may be a hallmark of the first stages of insulin resistance.
In the present study, we also found that the early stages of insulin resistance appear to be driven more by declines in nonoxidative glucose metabolism than by changes in oxidative metabolism. Consistent with this observation, Felber et al. 38 reported that the declines in both components of glucose disposal in obese adults were due to higher fat oxidation rates during insulin infusion (that is, a lower RQ). They hypothesized that hyperglycemia accompanying insulin resistance may serve to compensate for these defects in nonoxidative disposal. 38 This explanation is plausible, as Thorburn et al. 26 showed that when the GDR is raised to match that of nondiabetic controls, adults with diabetes have higher nonoxidative disposal and similar fat oxidation rates.
We also investigated how long-term overfeeding altered 24-h substrate oxidation rates. Protein oxidation was modestly increased, as reported in other overfeeding studies in initially lean healthy adults, 39-41 even after adjusting for increased energy requirements. Fat oxidation tended to be higher, but this difference did not reach statistical significance. However, carbohydrate oxidation in response to a eucaloric diet was not significantly different from baseline. Previous studies have reported that, in response to a hypercaloric challenge, shifts in substrate oxidation are dominated by the need to maintain carbohydrate balance, owing to its limited storage capacity (reviewed in Jebb et al. 41 ). Increases in carbohydrate intake are therefore buffered by almost equal increases in carbohydrate oxidation, even at carbohydrate excesses of up to roughly 30-50% of daily EE, before net de novo lipogenesis becomes physiologically important. 14, [40] [41] [42] [43] [44] [45] [46] Whereas carbohydrate intake stimulates its own oxidation, 44 several studies have shown that fat intake does not stimulate its own oxidation-at least not in the short term in lean healthy adults. 14, 43, 47, 48 For instance, two studies found that 50% carbohydrate overfeeding increased carbohydrate oxidation about twofold to match carbohydrate intake, and this change was accompanied by an increase in EE, whereas 50% fat overfeeding increased fat oxidation rates by only~20%, with no change in EE. 43, 46 Because carbohydrate balance is tightly regulated, whereas fat balance is not, it has thus been proposed that obesity may be driven by a failure to achieve fat balance. 38, 42 Indeed, studies in humans report that energy balance strongly correlates (r = 0.72-0.96) with fat balance in lean adults but not with carbohydrate or protein balance. 47, 49 However, we found no evidence supporting the hypothesis that metabolic adaptation is linked to higher fat oxidation rates. Instead, our data suggest that metabolic adaptation is mediated through increases in carbohydrate oxidation, not fat oxidation. Other overfeeding studies have hinted at similar results, finding that the increase in carbohydrate oxidation comes at the expense of a decrease in fat oxidation. 40, 41, 43, 45, 46, 50 In sum, we found that the early stages of insulin resistance in initially healthy individuals are accompanied by modest declines in RQ during sleep and during a clamp. However, MF is unchanged and may even be higher when measured during a 24-h stay in a respiratory chamber. Importantly, this suggests that impairments in insulin sensitivity and alterations in substrate oxidationparticularly during sleep and feeding-appear before declines in MF become apparent.
